Novartis AG
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
Last updated:
Abstract:
The invention provides compounds of Formula (I): ##STR00001## as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.
Status:
Grant
Type:
Utility
Filling date:
25 Aug 2017
Issue date:
24 Aug 2021